0001209191-19-033719.txt : 20190531
0001209191-19-033719.hdr.sgml : 20190531
20190531182615
ACCESSION NUMBER: 0001209191-19-033719
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190530
FILED AS OF DATE: 20190531
DATE AS OF CHANGE: 20190531
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brege Laura
CENTRAL INDEX KEY: 0001365619
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34207
FILM NUMBER: 19871717
MAIL ADDRESS:
STREET 1: C/O ONYX PHARMACEUTICALS, INC.
STREET 2: 2100 POWELL STREET
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0001029142
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330728374
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2929 SEVENTH STREET
STREET 2: SUITE 100
CITY: BERKELEY
STATE: CA
ZIP: 94710
BUSINESS PHONE: 5108485100
MAIL ADDRESS:
STREET 1: 2929 SEVENTH STREET
STREET 2: SUITE 100
CITY: BERKELEY
STATE: CA
ZIP: 94710
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-30
0
0001029142
DYNAVAX TECHNOLOGIES CORP
DVAX
0001365619
Brege Laura
C/O DYNAVAX TECHNOLOGIES
2929 7TH STREET, SUITE 100
BERKELEY
CA
94710
1
0
0
0
Option (Right to Buy)
4.97
2019-05-30
4
A
0
15000
A
2026-05-29
Common Stock
15000
15000
D
This option vests fully on May 30, 2020, on the one year anniversary of the grant date.
Not applicable.
Laura Brege, by /s/ Michael Ostrach, Attorney-in-Fact
2019-05-31